Number of pages: 100-120 | Report Format: PDF | Published date: 15 July, 2022
Historical Years – 2018 & 2019 | Base Year – 2020 | Forecasted Years – 2021 to 2031
The global liquid chromatography for biopharmaceuticals market was pegged at ~US$ 6,330.1 in 2021 and is expected to witness a CAGR of ~5.7% during the forecast period.
Liquid chromatography is an analytical tool, widely used in the pharmaceutical industry. The technique is used to separate the individual component from a certain sample. It is mainly used in biopharmaceuticals for the purification, identification, and separation of various compounds. Liquid chromatography comes in various techniques like ion exchange, affinity, and high-pressure liquid chromatography. Since biopharmaceuticals are derived from living cells, manufacturing involves complex procedures. This procedure may cause some impurities. Thus, liquid chromatography is used to ensure the efficacy and safety of the final product.
The global liquid chromatography for the biopharmaceuticals market is mainly driven by increasing pharmaceutical R&D spending, the growing importance of HPLC tests in drug approvals, and the rising application of chromatography in the purification of monoclonal antibodies. Furthermore, the growing popularity of coupled analytical techniques is also likely to play a critical role in contributing to the growth of the market globally. However, the high cost of equipment and dearth of skilled professionals is likely to restrain market growth to a certain extent.
The global liquid chromatography for biopharmaceuticals market has been analyzed from four perspectives: Technique, Type, End-User, and Region.
Liquid Chromatography for Biopharmaceuticals Market by Technique
The global liquid chromatography for biopharmaceuticals market has been segmented into high-pressure liquid chromatography (HPLC), low-pressure liquid chromatography (LPLC), ultra-high pressure liquid chromatography (UHPLC)/ultra-high pressure liquid chromatography (UPLC), and fast protein liquid chromatography (FPLC). Over the past few decades, high-performance liquid chromatography (HPLC) solutions and inputs have rapidly advanced with the development of biotherapeutics. HPLC coupled with mass spectrometry is commonly used characterization of biopharmaceuticals during drug development.
Liquid Chromatography for Biopharmaceuticals Market by Type
The global liquid chromatography for biopharmaceuticals market has been segmented into instruments, consumables, and software & accessories, based on type. Currently, the instruments segment is estimated to capture the largest revenue share in the global liquid chromatography for biopharmaceuticals market. The significant expense of instruments essentially adds to the prevailing place of this portion in the worldwide market. Increasingly more end clients are selecting the novel strategy instruments, for example, UPLC and MS gadgets which are additionally credited to the high-income portion of this fragment.
Liquid Chromatography for Biopharmaceuticals Market by End User
The global liquid chromatography for biopharmaceuticals market has been segmented into pharmaceutical companies, academics & research institutes, and contract research organizations (CROs). The increased demand for biopharmaceuticals to avoid the side effects linked with the usage of small molecules and increased investment associated with R&D have contributed to the growth of liquid chromatography for biopharmaceutical market.
Liquid Chromatography for Biopharmaceuticals Market by Region
Based on region, the global liquid chromatography for biopharmaceuticals market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (ROW). In terms of revenue, North America dominates the worldwide liquid chromatography market for biopharmaceuticals. Some of the biggest businesses producing biopharmaceuticals and laboratory equipment are in this area. The main drivers of this market in the region are the rising incidence of chronic diseases in North America and rising U.S. investment in the development of biopharmaceuticals. The United States is acknowledged as the global leader in life sciences innovation, and it participates in international capital investments in biopharmaceutical start-ups. Many biotech and pharmaceutical businesses in the United States worked to create effective COVID-19 medicines during the pandemic, which helped to expand the market at the time. the increasing prevalence of chronic illnesses.
Adding to this, liquid chromatography for the biopharmaceuticals market is predicted to have lucrative growth prospects due to the rising healthcare spending in the Asia Pacific region. The Indian market is characterized by rising stakeholder investment and expanding domestic government policy backing. Several research and manufacturing organizations are attracted to pipeline medication development and marketing because of the recognition and prominence that many biotech businesses and CROs are achieving on the global markets.
Some of the prominent players operating in the liquid chromatography for biopharmaceuticals market are